Forty patients undergoing routine bronchoscopy were randomised to receive inhaled micronised gentamicin powder (180 mg) or nebulised gentamicin solution (160 mg) one hour before the procedure. Similar levels of gentamicin were detected in bronchoalveolar lavage fluid in the two groups (micronised powder (n=20) 9 3 (SD 9 3) mgIl, nebulised solution (n = 20) 8-0 (7 8) mgl1). Gentamicin concentration in lavage fluid (mean and 95%
The micronised gentamicin powder preparation caused cough in half the patients but this did not stop their receiving a full dose. Dry powder gentamicin may be a convenient formulation for long term inhaled treatment if the problem of cough can be overcome.
In patients with cystic fibrosis colonised with pseudomonas regular administration of nebulised gentamicin and carbenicillin improves lung function and reduces the frequency of hospital admission. ' 
Half the patients who inhaled the powder preparation developed cough but this did not preclude administration of the full dose.
Discussion
We have shown that inhaled micronised gentamicin powder produces gentamicin concentrations in bronchoalveolar lavage fluid similar to those produced by gentamicin solution nebulised by an optimal method.3 Inhaling a dry powder preparation is quick, convenient, and clean and may be particularly suitable for patients with cystic fibrosis and bronchiectasis who wish to maintain an independent life style. The major problem with the system was cough and we do not believe that the current formulation would be tolerated on a long term basis. Coughing may have been due to the relatively large volume of powder in each capsule, leading to particle aggregation and deposition on the vocal cords, or to airway sensitivity to the powder. Possible solutions to this problem include pretreatment with an inhaled bronchodilator and a different formulation of the capsules; the latter appears to offer greater promise. Ideally a non-irritant preparation with a full dose in a single capsule is required, and further work on the pharmaceutical aspects of the preparation is in progress. Administration of micronised gentamicin powder can achieve adequate concentrations in the airways and this new delivery system for antibiotics may have therapeutic potential.
